Moderna Asks FDA For Emergency Approval For COVID-19 Vaccine It Says Is 94% Effective
Moderna is asking the Food and Drug Administration to fast track its vaccine later on Monday after new data from a Phase III trial showed it was 94% effective against the coronavirus.
We talk to Dr. Paul Offit, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia.
This article was originally published on WBUR.org.
Copyright 2020 NPR. To see more, visit https://www.npr.org.